Roswell, Georgia, based medical device company CorMatrix Cardiovascular has revealed that it has received approval from the US Food and Drug Administration to market its CanGaroo ECM Envelope implant to be used with cardiac implantable electronic devices (CIED's) including pacemakers and implantable cardioverter defibrillators (ICD's).
The device will be able to securely hold CIEDs, allowing a stable environment in which it can be implanted in the body.
AdvertisementThe CanGaroo ECM Envelope has been made using multi-laminate sheet of decellularized, non-crosslinked, lyophilized extracellular matrix (ECM) derived from porcine small intestinal submucosa and comes in four different sizes to accommodate a number of device types and sizes.
P New Laser-Based Imaging Tool can be Used to Map Effect of Drugs on Brain Here is How Pomegranate can Boost Skin Health M
You May Also Like